Support for this idea comes from the observation that LDN from patients with advanced adenocarcinoma had higher expression of activation/degranulation markers (57) such as CD11b (gelatinase granules) and CD66b (specific granules) than neutrophils from the same patient (58). This evidence concerns the gene CEACAM8 and adenocarcinoma.